{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:02:12Z","timestamp":1791576132285,"version":"4.3.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.humpath.2013.04.025","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T23:15:46Z","timestamp":1376608546000},"page":"2199-2203","source":"Crossref","is-referenced-by-count":19,"title":["Clinicopathologic significance of immunostaining of \u03b1-thalassemia\/mental retardation syndrome X-linked protein and death domain\u2013associated protein in neuroendocrine tumors"],"prefix":"10.1016","volume":"44","author":[{"given":"Shi-Fan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Kasajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica S.M.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Yang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Wen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2013.04.025_bb0005","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/PAS.0b013e31824aba59","article-title":"PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms","volume":"36","author":"Chan","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.04.025_bb0010","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"5-Decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2013.04.025_bb0015","first-page":"305","article-title":"Neuroendocrine tumors: a registry of 1,000 patients","volume":"54","author":"Yunes","year":"2008","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.humpath.2013.04.025_bb0020","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/cncr.23883","article-title":"Neuroendocrine tumor epidemiology: contrasting Norway and North America","volume":"113","author":"Hauso","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2013.04.025_bb0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00535-009-0194-8","article-title":"Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan","volume":"45","author":"Ito","year":"2010","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.humpath.2013.04.025_bb0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1677\/ERC-10-0126","article-title":"mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours","volume":"18","author":"Kasajima","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.humpath.2013.04.025_bb0035","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.humpath.2013.04.025_bb0040","doi-asserted-by":"crossref","first-page":"20369","DOI":"10.1074\/jbc.M401321200","article-title":"A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein","volume":"279","author":"Tang","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2013.04.025_bb0045","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0092-8674(95)90287-2","article-title":"Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome)","volume":"80","author":"Gibbons","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2013.04.025_bb0050","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1093\/hmg\/5.12.1899","article-title":"ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome","volume":"5","author":"Picketts","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.humpath.2013.04.025_bb0055","doi-asserted-by":"crossref","first-page":"10635","DOI":"10.1073\/pnas.1937626100","article-title":"The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies","volume":"100","author":"Xue","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.humpath.2013.04.025_bb0060","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1073\/pnas.0608056104","article-title":"Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation","volume":"104","author":"Nan","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.humpath.2013.04.025_bb0065","series-title":"WHO Classification of Tumours of the Digestive System","author":"Bosman","year":"2010"},{"key":"10.1016\/j.humpath.2013.04.025_bb0070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","article-title":"Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors","volume":"36","author":"Yachida","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.04.025_bb0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1600-0463.2011.02851.x","article-title":"Expressional and mutational analysis of ATRX gene in gastric, colorectal and prostate cancers","volume":"120","author":"Je","year":"2012","journal-title":"APMIS"},{"key":"10.1016\/j.humpath.2013.04.025_bb0080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.1207313","article-title":"Altered telomeres in tumors with ATRX and DAXX mutations","volume":"33","author":"Heaphy","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.humpath.2013.04.025_bb0085","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/modpathol.2012.53","article-title":"Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors","volume":"25","author":"de Wilde","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2013.04.025_bb0090","doi-asserted-by":"crossref","first-page":"e1002772","DOI":"10.1371\/journal.pgen.1002772","article-title":"Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway","volume":"8","author":"Lovejoy","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.humpath.2013.04.025_bb0095","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/NEN.0b013e3181e576cf","article-title":"Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival","volume":"69","author":"McDonald","year":"2010","journal-title":"J Neuropathol Exp Neurol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681771300227X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681771300227X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T18:52:55Z","timestamp":1539456775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681771300227X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S004681771300227X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2013.04.025","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}